Fuqua SAW - Search Results

1

Hormonal modulation of ESR1 mutant metastasis.

Gu G, Tian L, Herzog SK, Rechoum Y, Gelsomino L, Gao M, Du L, Kim JA, Dustin D, Lo HC, Beyer AR, Edwards DG, Gonzalez T, Tsimelzon A, Huang HJ, Fernandez NM, Grimm SL, Hilsenbeck SG, Liu D, Xu J, Alaniz A, Li S, Mills GB, Janku F, Kittler R, Zhang XH, Coarfa C, Foulds CE, Symmans WF, Andò S, Fuqua SAW. Gu G, et al. Among authors: fuqua saw. Oncogene. 2021 Feb;40(5):997-1011. doi: 10.1038/s41388-020-01563-x. Epub 2020 Dec 15. Oncogene. 2021. PMID: 33323970 Free PMC article.

2

Heat shock proteins and drug resistance.

Fuqua SA, Oesterreich S, Hilsenbeck SG, Von Hoff DD, Eckardt J, Osborne CK. Fuqua SA, et al. Breast Cancer Res Treat. 1994;32(1):67-71. doi: 10.1007/BF00666207. Breast Cancer Res Treat. 1994. PMID: 7819588 Review.

3

The small heat shock protein hsp27 is correlated with growth and drug resistance in human breast cancer cell lines.

Oesterreich S, Weng CN, Qiu M, Hilsenbeck SG, Osborne CK, Fuqua SA. Oesterreich S, et al. Cancer Res. 1993 Oct 1;53(19):4443-8. Cancer Res. 1993. PMID: 8402609

4

Multiple splicing variants of the estrogen receptor are present in individual human breast tumors.

Zhang QX, Hilsenbeck SG, Fuqua SA, Borg A. Zhang QX, et al. J Steroid Biochem Mol Biol. 1996 Nov;59(3-4):251-60. doi: 10.1016/s0960-0760(96)00120-3. J Steroid Biochem Mol Biol. 1996. PMID: 9010317

5

The small heat shock protein hsp27 increases invasiveness but decreases motility of breast cancer cells.

Lemieux P, Oesterreich S, Lawrence JA, Steeg PS, Hilsenbeck SG, Harvey JM, Fuqua SA. Lemieux P, et al. Invasion Metastasis. 1997;17(3):113-23. Invasion Metastasis. 1997. PMID: 9702938

6

Relationship of clone 4 estrogen receptor variant messenger RNA expression to some known prognostic variables in human breast cancer.

Murphy LC, Hilsenbeck SG, Dotzlaw H, Fuqua SA. Murphy LC, et al. Clin Cancer Res. 1995 Feb;1(2):155-9. Clin Cancer Res. 1995. PMID: 9815968

7

The small heat shock protein HSP27 is not an independent prognostic marker in axillary lymph node-negative breast cancer patients.

Oesterreich S, Hilsenbeck SG, Ciocca DR, Allred DC, Clark GM, Chamness GC, Osborne CK, Fuqua SA. Oesterreich S, et al. Clin Cancer Res. 1996 Jul;2(7):1199-206. Clin Cancer Res. 1996. PMID: 9816288

8

Statistical analysis of array expression data as applied to the problem of tamoxifen resistance.

Hilsenbeck SG, Friedrichs WE, Schiff R, O'Connell P, Hansen RK, Osborne CK, Fuqua SA. Hilsenbeck SG, et al. J Natl Cancer Inst. 1999 Mar 3;91(5):453-9. doi: 10.1093/jnci/91.5.453. J Natl Cancer Inst. 1999. PMID: 10070945

9

Loss of heterozygosity at D14S62 and metastatic potential of breast cancer.

O'Connell P, Fischbach K, Hilsenbeck S, Mohsin SK, Fuqua SA, Clark GM, Osborne CK, Allred DC. O'Connell P, et al. J Natl Cancer Inst. 1999 Aug 18;91(16):1391-7. doi: 10.1093/jnci/91.16.1391. J Natl Cancer Inst. 1999. PMID: 10451444

10

Hsp27 overexpression inhibits doxorubicin-induced apoptosis in human breast cancer cells.

Hansen RK, Parra I, Lemieux P, Oesterreich S, Hilsenbeck SG, Fuqua SA. Hansen RK, et al. Breast Cancer Res Treat. 1999 Jul;56(2):187-96. doi: 10.1023/a:1006207009260. Breast Cancer Res Treat. 1999. PMID: 10573111

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

187 results

Search Page